Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-11.55%
-21.81%
-4.37%
-8.66%
ABBV
AbbVie
$191.22
Chart
$186.98 (+2.27%)
$172.99 (+10.54%)
$210.75 (-9.27%)
$181.94 (+5.10%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-11.55%
-21.81%
-4.37%
-8.66%
ABBV
AbbVie
Current Price
$191.22
Login to view AbbVie (ABBV) recommendation from the last 90 days from financial news and social media.
Chart
$186.98 (+2.27%)
$172.99 (+10.54%)
$210.75 (-9.27%)
$181.94 (+5.10%)
ABBV Latest Analysis
Pre-Q2 Earnings: Is AbbVie Stock a Portfolio Must-Have?. ABBVs Q2 results are likely to hinge on Skyrizi and Rinvoq growth as Humira declines with 2025 set for a strong revenue rebound.
Mon Jul 28, 2025
Rheumatologists Eye AbbVies Rinvoq Roche/Genentechs Gazyva and Bristol Myers Squibbs Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care Spherix Global Insights Reports. EXTON PA July 23 2025 (GLOBE NEWSWIRE) -- Biologic use in systemic lupus erythematosus (SLE) is steadily rising with United States rheumatologists now treating close to 40% of their moderate-to-severe patients with biologics. Most expect this number to increase as comfort with existing therap
Wed Jul 23, 2025
Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight. Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 |. DelveInsightThe rising occurrence of dysmenorrhea along with greater awareness and advancements in diagnosis is driving substantial growth in the dysmenorrhea treatment market. With more women pursuing medical care for menstrual discomfort there is a growing demand for a wide range of treatment options including over-the-counter painkill
Wed Jul 23, 2025
4 Reasons To Buy AbbVie.
Tue Jul 22, 2025
Dementia Associated with Alzheimers Disease Drug Development Surges with 180 Companies Pushing New Therapeutic Frontiers | DelveInsight. Dementia Associated with Alzheimer'.s Disease Drug Development Surges with 180 Companies Pushing New Therapeutic Frontiers |. DelveInsightDementia associated with Alzheimer'.s disease is a progressive neurodegenerative condition characterized by memory loss cognitive decline and impaired daily functioning. The growing aging population worldwide is l
Thu Jul 17, 2025
AbbVie (ABBV) Surpasses Market Returns: Some Facts Worth Knowing. The latest trading day saw AbbVie (ABBV) settling at $190.58 representing a 2.25% change from its previous close.
Wed Jul 16, 2025
Looking Into AbbVies Recent Short Interest. ) short percent of float has risen 8.43% since its last report. The company recently reported that it has Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price ...
Wed Jul 16, 2025
Heres How to Play AbbVie Stock as it Reaches Golden Cross . ABBV hits a ish golden cross as Skyrizi and Rinvoq drive growth offsetting Humira losses and aesthetic headwinds.
Tue Jul 15, 2025
Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight. Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements |. DelveInsight The Waldenstrom macroglobulinemia market is witnessing steady growth driven by advances in targeted therapies particularly BTK inhibitors like IMBRUVICA and BRUKINSA. Rising awareness improved diagnostic techniques and increasing clinical trial activity ar
Mon Jul 14, 2025
Ex-Dividend Reminder: Buckle AbbVie and PNC Financial Services Group. Looking at the universe of stocks we cover at Dividend Channel on 7/15/25 Buckle Inc. (Symbol: BKE) AbbVie Inc (Symbol: ABBV) and PNC Financial Services Group (Symbol: PNC) will all trade ex-dividend for their respective upcoming dividends. Buckle Inc. will pay its quarter
Fri Jul 11, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ABBV Stock trends
ABBV Stock performance
ABBV Stock analysis
ABBV investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings